Aurobindo Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Aurobindo stock prediction for 2026 from leading brokerages and research analysts covers a wide range that reflects the company’s sector dynamics, earnings trajectory and macro environment. The Aurobindo stock prediction published in this article is sourced from publicly available research and may or may not be achieved. Investors should treat any Aurobindo share price prediction as one data point and not as a guarantee of future performance.

Interest in the Aurobindo stock forecast for 2026 has grown as investors look for anchor points in a volatile market. This article reviews every dimension of the Aurobindo stock prediction that analysts are tracking, including key business drivers, bull and bear scenarios and the primary risks that could shift the Aurobindo share price prediction in either direction. The analyst consensus for 2026 should be verified with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Aurobindo Stock in 2026

Analyst consensus on the Aurobindo stock prediction for 2026 is tracked by leading brokerages and research firms. The table below shows the latest available Aurobindo stock forecast data from UBS and ICICI Securities. All Aurobindo share price prediction figures are sourced from publicly available research and should be verified against the most current brokerage reports before publishing.

Brokerage	Rating	Aurobindo Stock Prediction (Rs)	Updated
UBS	Neutral	Rs 1,400	2026
ICICI Securities	Buy	Rs 1,600	2026
Analyst Consensus	—	Rs 1,500	2026

The Aurobindo stock prediction range from the analyst community reflects a genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. Each Aurobindo share price prediction from an individual brokerage should be read alongside the stated assumptions. The implied upside in the Aurobindo stock forecast from the current market price of Rs 1,462 may or may not be realised by the end of 2026.

Aurobindo Company Overview

Aurobindo Pharma is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Aurobindo stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk. Understanding this context is the starting point for any Aurobindo stock prediction and helps investors assess whether the analyst Aurobindo stock forecast is grounded in a realistic view of the company’s competitive position.

Metric	Value
NSE Ticker	AUROPHARMA
Sector	Pharmaceuticals and Healthcare
CMP	Rs 1,462 (2026)
52 Week High	Rs 1,550
52 Week Low	Rs 1,016
Market Cap	Rs 84,812 Cr
P/E Ratio	35.0
Aurobindo Stock Prediction Consensus (12M)	Rs 1,500

Aurobindo Stock Prediction by Time Horizon

Analysts split the Aurobindo share price prediction across different time frames because the variables that drive the short-term view are very different from those that shape a 3 to 5 year outlook. The following three horizons give a structured way to think about the range of analyst estimates for 2026 and beyond.

Short-Term Aurobindo Stock Prediction (1 to 3 Months)

The near-term analyst view on Aurobindo Pharma reflects current market sentiment, sector news flow and upcoming earnings data points. Analysts forming a short-term Aurobindo stock forecast are watching key support and resistance levels around the current market price of Rs 1,462. A Aurobindo share price prediction in the near term is the most uncertain of all time horizons and may or may not hold as new information emerges.

12-Month Aurobindo Stock Prediction

The 12 month Aurobindo stock prediction from leading brokerages represents the most widely cited analyst consensus for the full-year 2026 outlook. UBS has set a target of Rs 1,400 (Neutral) while ICICI Securities has set a target of Rs 1,600 (Buy). Most research desks refresh their Aurobindo stock forecast within two to four weeks of each quarterly earnings print. The Aurobindo share price prediction should be verified against the most recent analyst reports before being used as an investment reference.

Long-Term Aurobindo Stock Prediction

The long-term Aurobindo stock prediction, built on a 3 to 5 year view, is based on assumptions about demand recovery, margin expansion and revenue diversification. Analysts who set a higher long-term Aurobindo stock forecast cite the company’s structural growth drivers in the Pharmaceuticals and Healthcare sector. The long-term Aurobindo share price prediction should be treated as a directional indicator and may or may not prove accurate over the forecast period.

Aurobindo Stock Forecast: Key Factors Behind the Prediction

Understanding what drives the Aurobindo stock forecast requires reviewing the variables that most analysts reference when forming their Aurobindo share price prediction for 2026. The following four factors appear consistently in research reports on the Aurobindo stock prediction and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Aurobindo stock forecast. USFDA approval timelines and price erosion rates directly affect the Aurobindo share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Aurobindo stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Aurobindo share price prediction. New product approvals are cited as catalysts for the Aurobindo stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Aurobindo stock forecast. Margin recovery strengthens the Aurobindo share price prediction from most research desks.

Aurobindo Stock Prediction: Bull and Bear Scenarios

Any complete Aurobindo share price prediction must account for both positive and negative outcomes. The following scenarios are built from analyst commentary and sector data, representing the range of the Aurobindo stock prediction rather than a fresh estimate from Univest.

Scenario	Aurobindo Stock Prediction	Key Conditions
Bull Case	Rs 1,600	Strong business execution, margin improvement, favourable macro environment and sector re-rating
Base Case	Rs 1,500	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 1016	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Aurobindo stock forecast assumes most positive variables converge simultaneously. The bear case Aurobindo share price prediction reflects a scenario where demand deteriorates and the sector de-rates below current multiples. The base case Aurobindo stock prediction represents the analyst consensus view of Rs 1,500, which may or may not prove accurate.

How Analysts Are Reading the Aurobindo Stock Story

Analyst reviews of the Aurobindo share price prediction consistently highlight two opposing forces in 2026. The positive case for the Aurobindo stock forecast rests on the company’s core business strengths in the Pharmaceuticals and Healthcare sector, including competitive position and potential for margin or volume improvement over the next four quarters.

The cautious side of the analyst view points to near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Analysts who maintain a conservative Aurobindo stock prediction cite these as the primary reasons for staying neutral or cautious on the stock. Many research desks have revised their view since the start of 2026 as macro data evolved.

Overall, the Aurobindo stock prediction consensus from the analyst community is built on real business strengths set against real risks. Investors should read the full Aurobindo stock forecast report from each brokerage, including assumptions and risk disclosures, before using any Aurobindo share price prediction as an investment reference.

Key Risks That Could Change the Aurobindo Stock Prediction

Any Aurobindo share price prediction carries risks that could shift the Aurobindo stock forecast materially in either direction. Investors should review these risks before acting on any Aurobindo stock prediction from an analyst or research desk.

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Aurobindo stock prediction. A facility closure would force an immediate sharp revision to the Aurobindo share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Aurobindo stock forecast. Aggressive price erosion pushes the Aurobindo share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Aurobindo stock prediction. The Aurobindo share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Aurobindo stock forecast. Currency risk is embedded in conservative Aurobindo share price prediction models.

How to Monitor the Aurobindo Stock Forecast and Make Decisions

Start by opening a demat account with a SEBI registered broker if you do not already have one. Before acting on any Aurobindo share price prediction, ensure you understand the risks involved in equity investing.

Track the Aurobindo stock prediction consensus quarterly: after every earnings release, most brokerages revise their Aurobindo stock forecast within two weeks. Comparing the revised Aurobindo stock prediction to the previous estimate tells you whether analyst sentiment on the stock is improving or deteriorating.

Compare the current market price of Rs 1,462 with the analyst target range of Rs 1,400 to Rs 1,600. The Aurobindo share price prediction band can be wide, so position size should reflect that uncertainty.

Review the Aurobindo stock prediction every quarter against the key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many.

Download the Univest iOS App or Univest Android App to track the live Aurobindo stock prediction and Aurobindo share price prediction changes in real time.

Conclusion

The Aurobindo stock prediction for 2026 reflects the analyst community’s assessment of Aurobindo Pharma’s competitive position, earnings trajectory and macro environment. UBS sets a Neutral target of Rs 1,400 while ICICI Securities has a Buy target of Rs 1,600, giving an analyst consensus of Rs 1,500. The Aurobindo stock forecast is set against near-term risks that make the Aurobindo share price prediction range wide. Any estimate should be verified with the latest brokerage reports and does not constitute investment advice from Univest.

The analyst forecast will be revised after every quarterly result. Track the latest Aurobindo stock prediction and Aurobindo share price prediction changes on the Univest Screener and app to stay updated as 2026 progresses.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions on Aurobindo Stock Prediction 2026

What is the Aurobindo stock prediction for 2026?

Ans. The Aurobindo stock prediction for 2026 is based on analyst consensus from leading brokerages including UBS and ICICI Securities. The Aurobindo share price prediction range reflects the company’s fundamentals, sector outlook and macro environment. All estimates are analyst views and may or may not be achieved.

Is the Aurobindo stock prediction bullish or bearish?

Ans. The Aurobindo stock prediction for 2026 is divided, with UBS maintaining a Neutral stance with a target of Rs 1,400. The Aurobindo stock forecast consensus points to potential movement from current levels, though the Aurobindo share price prediction range is wide, reflecting macro uncertainty.

What is the Aurobindo share price prediction based on fundamentals?

Ans. The Aurobindo share price prediction built on fundamentals considers the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking the Aurobindo stock forecast closely cite these variables as the primary drivers of the 2026 outlook. Each analyst estimate may or may not reflect actual future performance.

What is the long-term Aurobindo stock prediction?

Ans. The long-term Aurobindo stock prediction is built around the assumption that the company’s core business drivers sustain over a multi-year horizon. Analysts with a higher Aurobindo stock forecast point to demand recovery, margin improvement and revenue diversification. The long-term estimate carries more uncertainty than the 12-month consensus of Rs 1,500.

What are the key risks to the Aurobindo stock prediction?

Ans. The key risks to the Aurobindo stock prediction in 2026 include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Analysts who set a lower Aurobindo share price prediction cite these as the primary downside risks. Every estimate should be read alongside its stated risk assumptions.

What does the Aurobindo stock forecast say for 2026?

Ans. The Aurobindo stock forecast for 2026 reflects a cautiously positive analyst consensus based on the company’s fundamental strengths. UBS has a Neutral rating with a target of Rs 1,400 while ICICI Securities has a Buy rating with a target of Rs 1,600. These Aurobindo share price prediction estimates may or may not prove accurate.

Where can I track the latest Aurobindo stock prediction?

Ans. You can track the latest Aurobindo stock prediction, live price and fundamentals on the official NSE and BSE websites and on the Univest app and screener, alongside every updated Aurobindo share price prediction and stock forecast from the analyst community.